Literature DB >> 6673092

Dermatofibrosarcoma protuberans. A clinico-pathological study of nineteen cases and review of world literature.

K Bendix-Hansen, O Myhre-Jensen, S Kaae.   

Abstract

The clinical course, pathological features and response to treatment in a consecutive 16-years series of 19 cases of dermatofibrosarcoma protuberans were studied. A review of the world literature, comparing the results to ours too was performed. The tumour, occurring at every age and equally among females and males, most commonly involves the trunk without any particular pattern. The disease usually runs an indolent course and is too often regarded lightly by patients as well as physicians leading to delayed and often too conservative treatment. The tumour has definite invasive and metastatic potential and is considered a low grade soft tissue sarcoma. To avoid mutilating surgery (and maybe metastases) later in the course, the initial treatment must be wide surgical excision including a surrounding margin of at least 1 inch normal tissue. The removal of underlying deep fascia is essential and adequate resection will require a skin graft replacement in nearly every instance. Follow up periods should be no less than 3 years at the surgical and oncological service and should be continued at the general practitioners because tumours may recur after considerable periods of time, even in apparently adequately treated patients.

Entities:  

Mesh:

Year:  1983        PMID: 6673092     DOI: 10.3109/02844318309013125

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg        ISSN: 0036-5556


  11 in total

1.  Treatment of dermatofibrosarcoma protuberans with Mohs micrographic surgery.

Authors:  E R Hobbs; R G Wheeland; P L Bailin; J L Ratz; R J Yetman; J E Zins
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  Congenital Dermatofibrosarcoma Protuberans: A Case Report and Literature Review.

Authors:  Hyun Ho Han; Soo Yeon Lim; Young Min Park; Jong Won Rhie
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

3.  Dermatofibrosarcoma protuberans--a clinicopathological study of ten cases.

Authors:  T K Chattopadhyay; M K Singh
Journal:  Jpn J Surg       Date:  1986-11

4.  Dermatofibrosarcoma protuberans: Our experience of 59 cases.

Authors:  Alessio Stivala; Giuseppe A G Lombardo; Gianluca Pompili; Maria Stella Tarico; Filippo Fraggetta; Rosario Emanuele Perrotta
Journal:  Oncol Lett       Date:  2012-08-30       Impact factor: 2.967

5.  Reconstructive challenge of dermatofibrosarcoma protuberans in the female breast.

Authors:  Tae Hwan Park; Sang Won Seo; June Kyu Kim; Choong Hyun Chang
Journal:  World J Surg Oncol       Date:  2011-01-07       Impact factor: 2.754

6.  Incidence and Clinical Features of Rare Cutaneous Malignancies in Olmsted County, Minnesota, 2000 to 2010.

Authors:  Stanislav N Tolkachjov; Adam R Schmitt; John G Muzic; Amy L Weaver; Christian L Baum
Journal:  Dermatol Surg       Date:  2017-01       Impact factor: 3.398

7.  Dermatofibrosarcoma: a rare neoplasm of skin.

Authors:  Rizwan Aziz; Anwer Jamil
Journal:  BMJ Case Rep       Date:  2012-11-21

8.  Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Authors:  Yanan Li; Jiaqi Liang; Xuewen Xu; Xian Jiang; Chuan Wang; Siyuan Chen; Bo Xiang; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-01-26       Impact factor: 4.123

Review 9.  Dermatofibrosarcoma protuberans treated by micrographic surgery.

Authors:  A Ah-Weng; J R Marsden; D S A Sanders; R Waters
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

Review 10.  [Dermatofibrosarcoma protuberans : report of 27 cases and review of the literature].

Authors:  Nawal Hammas; Ikram Badioui; Kaoutar Znati; Amal Benlemlih; Laila Chbani; Hind El Fatemi; Taoufiq Harmouch; Youssef Bouyahyaoui; Faouzi Boutayeb; Abdelmajid Mrini; Omar Mesbahi; Fatima Zahra Mernissi; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2014-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.